We are hiring a Clinical Study Manager
We are hiring a Clinical Study Manager! The Clinical Study Manager (CSM) is responsible for the overall management of allocated clinical trials in the CRO department, in accordance with International Conference on Harmonization Good Clinical Practices (ICH-GCP), applicable regulations, SOPs and Wis. Essential Duties and Responsibilities include, but are not limited to, the following: […]
Short Interview with Luisa Lopes
We have interviewed Luisa Lopes, the Leader of the Neurobiology of Ageing & Disease group at the Institute of Molecular Medicine (iMM) in Lisbon. In this short interview, Luisa talks about her research. She shares her opinion about the FDA approved Aduhelm (aducanumab) and how COVID-19 neurological complications are being addressed.
Short Interview with Susana Gonçalves
We have interviewed Susana Gonçalves, Operations Director at TechnoPhage. Susana talks about her experience in working with VectorB2B in the management of TechnoPhage clinical trials and shares her opinion about how she thinks companies like TechnoPhage could benefit from working with VectorB2B. https://www.youtube.com/watch?v=YFcnz7r28Ng
Short Interview with Mariana Almeida
We have interviewed Mariana Almeida, Innovation & Pharmaceutical Development Manager at Grupo Medinfar. During this short interview, Mariana talks about Medinfar and the role of VectorB2B as a one-stop-shop, offering full drug development services. https://www.youtube.com/watch?v=D-1kYWt9gi4&t=1s
Short Interview with Francisco Ambrósio
We have interviewed Francisco Ambrósio, Director of the Coimbra Institute for Clinical and Biomedical Research (iCBR) at Faculty of Medicine Coimbra University. During this short interview, Francisco talks about the research performed in his laboratory and how VectorB2B can help to bridge the translational gap. https://www.youtube.com/watch?v=OZwY5la4j6A
A new decade, a new framework for European funding
A new decade. A new framework for European Funding In recent times, no other year has been as challenging as 2020. The turn of the decade brought with it a worldwide pandemic and an abrupt stop to the economic growth in most countries. These are, without a doubt, the most testing times for most, if […]